Studies in Sweden and Germany indicate that underweight women with multiple sclerosis who take the MS drug Gilenya (fingolimod) seem to be at increased risk for lymphopenia. The drug also poses a risk for patients who have low lymphocyte levels before they start drug treatment.
Lymphopenia (also known as lymphocytopenia) is a condition in which a person has a deficiency (penia) of lymphocytes, which are a subset of white blood cells (leukocytes). Lymphocytes, which can be T cells, B cells, or natural killer cells, play a crucial role in supporting immune system function.... Read More - http://www.ms-uk.org/gilenya
MS drug Gilenya may increase risk of lymphopenia
MS drug Gilenya may increase risk of lymphopenia
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 1 Replies
- 5044 Views
-
Last post by ElliotB
-
- 5 Replies
- 13506 Views
-
Last post by gibbledygook
-
- 0 Replies
- 2311 Views
-
Last post by NHE
-
- 6 Replies
- 6702 Views
-
Last post by ElliotB
-
- 0 Replies
- 1362 Views
-
Last post by NHE
-
- 0 Replies
- 3434 Views
-
Last post by NHE
-
- 1 Replies
- 1027 Views
-
Last post by NHE
-
- 11 Replies
- 3386 Views
-
Last post by NHE
-
- 1 Replies
- 1523 Views
-
Last post by NHE